Industry
New Technology Licensed to Beckman Coulter
Under the terms of a licensing agreement signed by the two parties, Critical Therapeutics has granted certain rights in its patents, patent applications, and other intellectual property relating to its high mobility group box protein 1 (HMGB1) technology to Beckman Coulter More...15 Feb 2005
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
HPV Test
Allplex HPV28 Detection
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
In Other News
New Blood-Testing Methods Licensed to Quest
Alliance for New Automation Technologies
New Protein Technology Licensed to Beckman Coulter
Oxford and Pfizer to Develop POC Tests
Reagent Technology Licensed to Olympus Diagnostica
MorphoSys Extends Deal with Schering
Trestle to Acquire Interscope Technologies
Diagnocure Acquires Rights to Breast Cancer Markers
Biofile Acquires Biofons' ELISA Products
Pelikan Technologies Acquires Inventus BioTech
Iceland Genomics and Aclara in Biomarker Alliance
Collaboration on Lab Order Entry System
Paris Hosts Journees Internationales de Biologie
MedCap Acquires Rights to Syphilis Test
SomaLogic Receives Innovation Award
Odyssey Licenses in Vitro Technology to Panbio
Parent of Fujirebio to Integrate with SRL in Japan
Pall and Kawasumi Announce Marketing Agreement
Bio-Rad in HIV Licensing Deal with Calypte
David Pall, Founder of Pall Corporation, Dies at 90.
Escalon Acquires About 94% of Drew Scientific
Collaboration to Identify Autoimmune Markers
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
